Philippe Valadon

Characterization of a Murine Monoclonal Antibody to<i>Cryptococcus neoformans</i>Polysaccharide That Is a Candidate for Human Therapeutic Studies

Arturo Casadevall, Wendy Cleare, Marta Feldmesser et al. · Antimicrobial Agents and Chemotherapy · 1998 · 306 citations · Full text

Life Sciences, Immunology, Microbiology +16

Peptide inhibition of glomerular deposition of an anti-DNA antibody

Bruce D. Gaynor, Chaim Putterman, Philippe Valadon et al. · Proceedings of the National Academy of Sciences · 1997 · 189 citations

Life Sciences, Immunology, Nephrology +17

Peptide Libraries Define the Fine Specificity of Anti-polysaccharide Antibodies toCryptococcus neoformans

Philippe Valadon, Gabriel Nussbaum, Lisa F. Boyd et al. · Journal of Molecular Biology · 1996 · 135 citations

Pharmacy, Immunology, Microbiology +15

Melanization of <i>Cryptococcus neoformans</i> in Murine Infection

Joshua D. Nosanchuk, Philippe Valadon, Marta Feldmesser et al. · Molecular and Cellular Biology · 1999 · 130 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Specificity of in vitro Covalent Binding of Tienilic Acid Metabolites to Human Liver Microsomes in Relationship to the Type of Hepatotoxicity: Comparison with Two Directly Hepatotoxic Drugs

Sylvaine Lecoeur, Eric Bonierbale, Dominique Challine et al. · Chemical Research in Toxicology · 1994 · 127 citations

Pharmacy, Pharmacology, Toxicology +10